Bolt Biotherapeutics
Redwood City
About Bolt Biotherapeutics
Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy. Its platform, Boltbody, is a cancer immunotherapy that consists of immune-stimulating antibody conjugates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $198.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2021)
- Ticker: nasdaq:BOLT
- Website: boltbio.com
- Phone: (310)909-3218
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/bolt-biotherapeutics-16199 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.